Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Harry H, Yoon"'
Autor:
Christopher L. Hallemeier, MD, Kenneth W. Merrell, MD, Michelle A. Neben-Wittich, MD, Krishan R. Jethwa, MD, Harry H. Yoon, MD, Henry C. Pitot, MD, Shanda Blackmon, MD, K. Robert Shen, MD, Erik J. Tryggestad, PhD, Broc Giffey, CMD, Bret D. Kazemba, CMD, Jason K. Viehman, MS, William S. Harmsen, MS, Michael G. Haddock, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 8, Pp 101547- (2024)
Purpose: To evaluate the safety and efficacy of pencil beam scanning (PBS) proton radiation therapy (RT) in trimodality therapy for esophageal cancer. Methods and Materials: This prospective pilot study was planned to accrue 30 patients with locally
Externí odkaz:
https://doaj.org/article/e6c33f8f9d8a495f9155ba7f53fa443f
Autor:
Roman O. Kowalchuk, Grant M. Spears, Lindsay K. Morris, Dawn Owen, Harry H. Yoon, Krishan Jethwa, Michael D. Chuong, Matthew J. Ferris, Michael G. Haddock, Christopher L. Hallemeier, Dennis Wigle, Steven H. Lin, Kenneth W. Merrell
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Purpose/objectivePostoperative toxicity for esophageal cancer impacts patient quality of life and potentially overall survival (OS). We studied whether patient and toxicity parameters post-chemoradiation therapy predict for post-surgical cardiopulmon
Externí odkaz:
https://doaj.org/article/23f2d6302263427d9034c7e70803efb9
Autor:
Wei Deng, MD, Krishan R. Jethwa, MD, Karthik Gonuguntla, MD, Zhongxing Liao, MD, Harry H. Yoon, MD, Mariela Blum Murphy, MD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD, Steven H. Lin, MD PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 951-958 (2020)
Purpose: To evaluate the safety and efficacy of definitive chemoradiotherapy (CRT) for patients with clinical T1N0M0 esophageal adenocarcinoma. Methods and Materials: This was a retrospective study of patients with clinical T1N0 adenocarcinoma of the
Externí odkaz:
https://doaj.org/article/c49f54d9fa6b428ab649943d058b8c26
Autor:
Daniel Walden, Mohamad Bassam Sonbol, Skye Buckner Petty, Harry H. Yoon, Mitesh Borad, Tanios S. Bekaii-Saab, Daniel H. Ahn
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundFluoropyrimidine with platinum-based chemotherapy has become the standard of care for advanced gastric and gastroesophageal (GEJ) cancer. Trials in colon cancer show that induction chemotherapy followed by maintenance chemotherapy is an eff
Externí odkaz:
https://doaj.org/article/01f60d4e3190474e91faeb189c39f67a
Autor:
Jianming Xu, Ken Kato, Eric Raymond, Richard A Hubner, Yongqian Shu, Yueyin Pan, Sook Ryun Park, Lu Ping, Yi Jiang, Jingdong Zhang, Xiaohong Wu, Yuanhu Yao, Lin Shen, Takashi Kojima, Evgeny Gotovkin, Ryu Ishihara, Lucjan Wyrwicz, Eric Van Cutsem, Paula Jimenez-Fonseca, Chen-Yuan Lin, Lei Wang, Jingwen Shi, Liyun Li, Harry H Yoon
Publikováno v:
The Lancet Oncology. 24:483-495
Publikováno v:
Journal of Gastrointestinal Oncology. 14:435-441
Autor:
Edoardo Francini, Fang-Shu Ou, Stefano Lazzi, Roberto Petrioli, Andrea G. Multari, Guido Pesola, Luciana Messuti, Elena Colombo, Virginia Livellara, Serena Bazzurri, Sara Cherri, Salvatora T. Miano, Eric G. Wolfe, Steven R. Alberts, Joleen M. Hubbard, Harry H. Yoon, Guido Francini
Publikováno v:
Translational Oncology, Vol 14, Iss 2, Pp 100973- (2021)
Background: High tumor infiltrating lymphocytes (TILs) density was previously shown to be associated with favorable prognosis for patients with colon cancer (CC). However, the impact of TILs on overall survival (OS) of stage II CC patients who receiv
Externí odkaz:
https://doaj.org/article/bb727b9e9ca8480e8ece3bee7ce744b5
Autor:
David G. DeNardo, Brett H. Herzog, William G. Hawkins, Olivia Aranha, Lee Ratner, Nikolaos A. Trikalinos, Mojun Zhu, Harry H. Yoon, Feng Gao, Mina Abdiannia, Abhi Acharya, Nicholas Boice, Benjamin Tan, Katrina Pedersen, Savannah J. Bogner, John Herndon, Jad I. Belle, Marcus Breden, Amberly Brown, Albert C. Lockhart, Rama Suresh, Robert McWilliams, Kian-Huat Lim, Andrea Wang-Gillam
Purpose:Targeting focal adhesion kinase (FAK) renders checkpoint immunotherapy effective in pancreatic ductal adenocarcinoma (PDAC) mouse model. Defactinib is a highly potent oral FAK inhibitor that has a tolerable safety profile.Patients and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::498ad6f1abd0445dee85ccf4a8aca1eb
https://doi.org/10.1158/1078-0432.c.6532836
https://doi.org/10.1158/1078-0432.c.6532836
Autor:
David G. DeNardo, Brett H. Herzog, William G. Hawkins, Olivia Aranha, Lee Ratner, Nikolaos A. Trikalinos, Mojun Zhu, Harry H. Yoon, Feng Gao, Mina Abdiannia, Abhi Acharya, Nicholas Boice, Benjamin Tan, Katrina Pedersen, Savannah J. Bogner, John Herndon, Jad I. Belle, Marcus Breden, Amberly Brown, Albert C. Lockhart, Rama Suresh, Robert McWilliams, Kian-Huat Lim, Andrea Wang-Gillam
Supplemental Table 2 Patient demographics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::225bff0f9fcf13662fb64bc5994a0c65
https://doi.org/10.1158/1078-0432.22488921
https://doi.org/10.1158/1078-0432.22488921
Autor:
Harry H. Yoon, Shanda Blackmon, Chris L. Hallemeier, Daniel H. Ahn, Dennis Wigle, Haidong Dong, Tanios S. Bekaii-Saab, Wen Wee Ma, Bing Q. Huang, Fabrice Lucien, Robert R. McWilliams, Joerg Herrmann, Yening Feng, Cristobal T. Sanhueza, Henry C. Pitot, Susan M. Harrington, Yohan Kim, Staci E. Beamer, Briant F. Fruth, Marcela A. Salomao, Taofic Mounajjed, Christopher Hartley, Nathan R. Foster, Chunhua Chen, Mojun Zhu
Supplementary Data from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e4d75aa912e65c6dd946e31ee2b131
https://doi.org/10.1158/1078-0432.22486523
https://doi.org/10.1158/1078-0432.22486523